Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients
jRCT2080221396Phase 3
- Sponsor
- Japan Tobacco
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic kidney disease (CKD) comparing JTT-751 with Placebo (2 arms).
02
Drugs
ferric citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080221396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221396.